In modern healthcare, accurate and reliable diagnostic tools play a pivotal role in assessing bone health. One such advanced ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

In addition, using dual energy x-ray absorptiometry (DXA), the areal bone mineral density (aBMD) and bone mineral content (BMC) have been shown to be reduced in studies involving 20 (13 ...

Romosozumab plus alendronate led to a greater improvement in bone strength than alendronate alone in postmenopausal women ...

The long-acting progestogen injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate have been found to adversely affect bone mineral density in adult premenopausal ...

Objective Normal-weight oligo-amenorrhoeic athletes (OAA) are at risk for low bone mineral density (BMD). Data are lacking regarding the impact of oestrogen administration on bone outcomes in OAA. Our ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.